Depressive Disorders - Switzerland

Revenue in the Depressive Disorders market is projected to reach US$166.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.06%, resulting in a market volume of US$167.40m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$367.50 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Switzerland is experiencing steady growth due to several factors.

Customer preferences: Swiss customers have shown a growing preference for seeking mental health treatment, including therapy and medication, for depressive disorders. This is largely driven by increased awareness and understanding of mental health issues, as well as a decreasing stigma surrounding mental health in the country. Swiss customers are also more likely to seek professional help for depressive disorders due to the high level of trust in the healthcare system and the availability of healthcare professionals specializing in mental health.

Trends in the market: One of the key trends in the Depressive Disorders market in Switzerland is the increasing use of digital platforms for mental health support. With the widespread adoption of smartphones and internet access, Swiss customers are turning to online therapy and mental health apps as a convenient and accessible way to manage their depressive disorders. This trend is further accelerated by the COVID-19 pandemic, which has limited in-person interactions and increased the demand for remote mental health services.Another trend in the market is the growing interest in alternative therapies and holistic approaches to treating depressive disorders. Swiss customers are increasingly seeking out complementary therapies such as mindfulness, yoga, and acupuncture, in addition to traditional treatment methods. This trend is driven by a desire for a more holistic and personalized approach to mental health, as well as a growing body of research supporting the effectiveness of these alternative therapies.

Local special circumstances: Switzerland has a well-developed healthcare system with a strong focus on mental health. The country has a high number of mental health professionals per capita, making it easier for Swiss customers to access the necessary treatment for depressive disorders. Additionally, the Swiss government has implemented policies and initiatives to promote mental health awareness and provide support for those suffering from mental health issues, further driving the growth of the Depressive Disorders market.

Underlying macroeconomic factors: Switzerland has a high standard of living and a strong economy, which allows its citizens to afford the necessary healthcare services and medications for the treatment of depressive disorders. The country also has a comprehensive health insurance system that covers mental health services, making it more affordable for Swiss customers to seek treatment. Furthermore, the aging population in Switzerland is contributing to the growth of the Depressive Disorders market, as older individuals are more likely to experience depressive disorders and require treatment.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.